UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2690) 2690
science & technology (2319) 2319
life sciences & biomedicine (2278) 2278
male (1931) 1931
tetrazoles - therapeutic use (1747) 1747
female (1637) 1637
middle aged (1394) 1394
tetrazoles - adverse effects (1263) 1263
aged (1197) 1197
hypertension - drug therapy (1131) 1131
cardiovascular system & cardiology (989) 989
treatment outcome (861) 861
antihypertensive agents - therapeutic use (846) 846
biological and medical sciences (819) 819
tetrazoles - administration & dosage (818) 818
medical sciences (812) 812
adult (762) 762
blood pressure - drug effects (755) 755
hypertension (714) 714
valsartan (701) 701
pharmacology & pharmacy (699) 699
antihypertensive agents - adverse effects (662) 662
tetrazoles - pharmacology (638) 638
valine - analogs & derivatives (635) 635
double-blind method (592) 592
drug therapy, combination (588) 588
angiotensin ii type 1 receptor blockers - therapeutic use (570) 570
cardiac & cardiovascular systems (543) 543
pharmacology. drug treatments (514) 514
peripheral vascular disease (508) 508
animals (488) 488
biphenyl compounds - therapeutic use (420) 420
antihypertensive agents - administration & dosage (415) 415
valine - therapeutic use (408) 408
hypertension - physiopathology (403) 403
benzimidazoles - therapeutic use (401) 401
angiotensin ii type 1 receptor blockers - adverse effects (386) 386
drug therapy (373) 373
abridged index medicus (365) 365
angiotensin receptor antagonists (362) 362
imidazoles - therapeutic use (362) 362
heart failure - drug therapy (350) 350
prospective studies (341) 341
biphenyl compounds - adverse effects (333) 333
imidazoles - adverse effects (329) 329
dose-response relationship, drug (328) 328
time factors (319) 319
blood pressure (315) 315
cardiovascular system (310) 310
heart failure (310) 310
cardiology. vascular system (295) 295
aged, 80 and over (290) 290
angiotensin (279) 279
risk factors (277) 277
angiotensin-converting enzyme inhibitors - therapeutic use (271) 271
general & internal medicine (256) 256
valine - adverse effects (256) 256
medicine, general & internal (248) 248
internal medicine (243) 243
cilostazol (242) 242
tetrazoles - pharmacokinetics (240) 240
antihypertensive agents (232) 232
medicine & public health (230) 230
antihypertensive agents - pharmacology (227) 227
rats (225) 225
benzimidazoles - adverse effects (222) 222
drug combinations (221) 221
randomized controlled trials as topic (221) 221
follow-up studies (218) 218
blood and lymphatic vessels (211) 211
hydrochlorothiazide - therapeutic use (206) 206
valine - administration & dosage (202) 202
angiotensin ii type 1 receptor blockers - administration & dosage (195) 195
care and treatment (192) 192
research (191) 191
amlodipine - therapeutic use (188) 188
hypertension - complications (185) 185
olmesartan medoxomil (184) 184
analysis (181) 181
platelet aggregation inhibitors - therapeutic use (180) 180
biphenyl compounds - administration & dosage (176) 176
hydrochlorothiazide - administration & dosage (176) 176
candesartan (175) 175
losartan (175) 175
hydrochlorothiazide - adverse effects (173) 173
mortality (172) 172
arterial hypertension. arterial hypotension (169) 169
heart failure - physiopathology (167) 167
angiotensin ii type 1 receptor blockers - pharmacology (166) 166
benzimidazoles - administration & dosage (166) 166
cardiology (166) 166
clinical trials (163) 163
biphenyl compounds - pharmacology (162) 162
imidazoles - administration & dosage (161) 161
pharmacology/toxicology (161) 161
dosage and administration (160) 160
irbesartan (158) 158
cardiovascular (157) 157
angiotensin receptor antagonists - therapeutic use (156) 156
tetrazoles (155) 155
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2904) 2904
German (72) 72
Japanese (47) 47
Spanish (28) 28
French (21) 21
Russian (21) 21
Chinese (14) 14
Swedish (7) 7
Danish (5) 5
Portuguese (5) 5
Dutch (3) 3
Hungarian (3) 3
Italian (3) 3
Czech (2) 2
Norwegian (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Cardiology. Vascular system | Arterial hypertension. Arterial hypotension | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Clinical manifestations. Epidemiology. Investigative techniques. Etiology | Blood and lymphatic vessels | Antihypertensive agents | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 04/2017, Volume 38, Issue 15, pp. 1132 - 1143
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 993 - 1004
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Heart Failure - drug therapy | Stroke Volume | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Neprilysin - antagonists & inhibitors | Female | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Heart Failure - mortality | Heart failure | Enalapril | Patient outcomes | Angiotensin | Enalaprilat | Dosage and administration | Research | Drug therapy | Enzymes | Statistical analysis | Mortality | Angioedema | Hypotension | Cough | Studies | Hyperkalemia | Death | Neprilysin | Heart diseases | Index Medicus | Abridged Index Medicus | MORTALITY | SURVIVAL | RANDOMIZED-TRIAL | RECEPTOR | Klinisk medicin | NEUTRAL ENDOPEPTIDASE INHIBITION | NATRIURETIC-PEPTIDE | Medicine | Clinical Medicine | CONVERTING ENZYME-INHIBITION | MORBIDITY | EJECTION FRACTION | General & Internal | DOUBLE-BLIND
Journal Article
Journal Article
Clinical pharmacology in drug development, ISSN 2160-763X, 11/2015, Volume 4, Issue 6, pp. 407 - 417
LCZ696 | pharmacokinetic drug–drug interaction | amlodipine | hydrochlorothiazide | carvedilol | Pharmacokinetic drug-drug interaction | Amlodipine | Hydrochlorothiazide | Carvedilol | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydrochlorothiazide - pharmacokinetics | Diuretics - pharmacokinetics | Humans | Middle Aged | Male | Metabolic Clearance Rate | Tetrazoles - blood | Adrenergic beta-Antagonists - pharmacokinetics | Drug Interactions | Tetrazoles - administration & dosage | Adrenergic beta-Antagonists - adverse effects | Amlodipine - administration & dosage | Arizona | Diuretics - blood | Hydrochlorothiazide - adverse effects | Diuretics - administration & dosage | Administration, Oral | Amlodipine - adverse effects | Propanolamines - adverse effects | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Cross-Over Studies | Models, Biological | Calcium Channel Blockers - administration & dosage | Protease Inhibitors - blood | Calcium Channel Blockers - blood | Propanolamines - administration & dosage | Diuretics - adverse effects | Tetrazoles - pharmacokinetics | Angiotensin Receptor Antagonists - adverse effects | Angiotensin Receptor Antagonists - pharmacokinetics | Calcium Channel Blockers - adverse effects | Area Under Curve | Protease Inhibitors - pharmacokinetics | Carbazoles - administration & dosage | Aminobutyrates - adverse effects | Antihypertensive Agents - administration & dosage | Healthy Volunteers | Propanolamines - pharmacokinetics | Amlodipine - pharmacokinetics | Aminobutyrates - pharmacokinetics | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Carbazoles - blood | Aminobutyrates - administration & dosage | Drug Therapy, Combination | Propanolamines - blood | Hydrochlorothiazide - blood | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - blood | Carbazoles - adverse effects | Amlodipine - blood | Drug Administration Schedule | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Neprilysin - metabolism | Aminobutyrates - blood | Angiotensin Receptor Antagonists - blood | Carbazoles - pharmacokinetics | Neprilysin - antagonists & inhibitors | Tetrazoles - adverse effects | Calcium Channel Blockers - pharmacokinetics | Angiotensin Receptor Antagonists - administration & dosage | Prescription drugs | Beta blockers | Index Medicus
Journal Article